Mitochondrial capacity is affected by glycemic status in young untrained women with type 1 diabetes but is not impaired relative to healthy untrained women ABSTRACT In this study, we examined whether glycemic status influences aerobic function in women with type 1 diabetes and whether aerobic function is reduced relative to healthy women. To this end, we compared several factors determining aerobic function of 29 young sedentary asymptomatic women (CON) with 9 women of similar age and activity level with type 1 diabetes [DIA, HbA1c range = 6.9−8.2%]. Calf muscle mitochondrial capacity was estimated by 31 P-Magnetic Resonance Spectroscopy. Capillarization and muscle fiber oxidative enzyme activity were assessed from vastus lateralis and soleus muscle biopsies. Oxygen uptake and cardiac output were evaluated by ergospirometry and N 2 O/SF 6 rebreathing. Calf muscle mitochondrial capacity was not different between CON and DIA, as indicated by the identical calculated maximal rates of oxidative ATP synthesis [0.0307 (0.0070) vs. 0.0309 (0.0058) s −1 , P = 0.930]. Notably, HbA1c was negatively correlated with mitochondrial capacity in DIA (R 2 = 0.475, P = 0.040). Although HbA1c was negatively correlated with cardiac output (R 2 = 0.742, P = 0.013) in DIA, there was no difference between CON and DIA in maximal oxygen consumption [2.17 (0.34) vs. 2.21 (0.32) l . min −1 , P = 0.764], cardiac output [12.1 (1.9) vs. 12.3 (1.8) l . min −1 , P = 0.783], and endurance capacity [532 (212) vs. 471 (119) s, P = 0.475].
INTRODUCTION
Aerobic function depends on the transport of oxygen from ambient air to the mitochondrial respiratory chain, and relies on a coordinated action between several processes (i.e. ventilation, blood flow, diffusion), which depends on distinct structures (i.e. lung, heart, capillaries, muscle fibers, mitochondria). Maximal oxygen uptake is determined by convective (perfusive) and diffusive oxygen transport capacity (30) . Whereas convective oxygen transport capacity (i.e. oxygen delivery) is given by the product of arterial oxygen content and cardiac output, diffusive oxygen transport capacity is determined by arterialmixed venous oxygen difference, which in turn relies on capillary supply and mitochondrial capacity (32) . Aerobic function is reduced in several chronic diseases, e.g. chronic heart failure (11) , chronic obstructive pulmonary disease (19) , and possibly in type 2 diabetes (29) .
However, the available data on the relationship between aerobic function and type 1 diabetes are contradictory. Some authors report decreased peak oxygen uptake and/or reduced submaximal cardiac output (15, 24, 27 ), yet, other investigators showed that peak oxygen uptake is not affected in patients with type 1 diabetes (13, 17, 37) . However, none of these authors have concurrently investigated both skeletal muscle structure and in vivo (mitochondrial) function, and combined these data with the functional assessment of peak oxygen uptake and peak cardiac output. Using 31 P-Magnetic Resonance Spectroscopy (MRS), Crowther et al. (8) found that mitochondrial capacity (i.e. the calculated maximal rate of oxidative ATP synthesis) is reduced in male patients with type 1 diabetes compared to healthy controls, and they suggested that reduced muscle mitochondrial capacity in conjunction with increased glycolytic flux represents a metabolic shift common to chronic metabolic diseases (obesity, type 1 and 2 diabetes). However, Holloszy (18) recently estimated that even if mitochondrial capacity was reduced, skeletal muscle still would 5 contain sufficient mitochondria to allow a ~150-fold increase in oxygen uptake per kg of muscle under exercise conditions. Therefore, it is questionable whether and to which extent reduced mitochondrial capacity may limit aerobic function.
Taken together, it is currently not well understood a) whether skeletal muscle structure and in vivo metabolic function are abnormal in patients with type 1 diabetes at all, b) whether possible impairments in these 'peripheral' factors coincide with possible impairments in maximal oxygen uptake, c) whether and to which extent a reduction in maximal cardiac output also contributes to the decrease in maximal oxygen uptake, and d) if glycemic status influences aerobic function. In this study we tested if aerobic function and its determinants are reduced in young women with type 1 diabetes relative to healthy women of similar age and physical activity level. To this end, we compared maximal oxygen uptake, maximal cardiac output, calculated arterio-venous oxygen difference, 31 P-MRS-derived calculated maximal rates of calf muscle oxidative ATP synthesis, vastus lateralis and soleus muscle fiber metabolic phenotype and capillarization between the two groups. In addition, we assessed ventilatory threshold and endurance capacity to investigate differences in submaximal exercise capacity between the two groups.
We hypothesized that if peak stroke volume, cardiac output, mitochondrial capacity, capillarization and oxidative enzymes were significantly reduced in women with type 1 diabetes relative to healthy controls, we should find a corresponding decrease in maximal oxygen uptake. Moreover, we hypothesized that if the possible impairments were confined to mitochondrial capacity, capillarization and oxidative enzymes only (i.e. without concurrent reduction in maximum cardiac output), we still might observe a reduction in maximal oxygen uptake, and consequently a decreased calculated peak arterio-venous oxygen difference. 6 
DESIGN AND METHODS

Participants
We recruited 29 young sedentary asymptomatic women (CON) and 9 women of similar age and activity level with type 1 diabetes (DIA). Mean age was 24.1 (SD 4.2) years for CON and 26.9 (5.2) years for DIA without significant difference. The participants' anthropometric data are presented in Table 1 . Women with type 1 diabetes had no diabetic complications or coexisting cardiovascular diseases, and were classified as C-peptide negative (< 0.5 μU . ml −1 ).
The duration of diabetes was 13.1 (6.6) years. Relative (per kg body mass) mean total daily insulin dose was 0.6 (0.3) units . kg −1 . Glycosylated hemoglobin A1c (HbA1c) was 5.3 (0.2) (range 5.0−5.7%) and 7.6 (0.4) % (range 6.9−8.2%) for CON and DIA, respectively, and different between groups (P < 0.001). Participants in the CON group showed no sign of Magnetic resonance spectroscopy and imaging measurements 31 P-MRS scans were acquired at rest and during isometric muscle contraction using a 3 T whole body Philips Achieva Scanner (Philips Healthcare, Best, The Netherlands) with a transmit/receive surface coil (diameter: 0.14 m) tuned to 51.8 MHz. The MR-compatible 7 ergometer setup was compound of a dynamometer with an integrated strain gauge (Sensory-Motor Lab, ETH Zurich, Switzerland) for force measurements and a real-time visual feedback system for providing the participants with information on the level of exerted force relative to maximal voluntary force. 31 P-MRS spectra of the triceps surae muscles were acquired using a pulse-acquire technique and an adiabatic hyperbolic secant excitation pulse.
The test protocol consisted of isometric plantarflexion at 85% of the maximal force acting on the pedal (MVF P ) for 30 s. Sequence parameters included: repetition time = 1.5 s, 3 signal averages per time point, 2048 sample points, 5 dummy scans; 20 spectra were recorded before the exercise for saturation correction; total number of spectra: 84. Recovery spectra were measured after cessation of the isometric contraction for 324 s. The reasons for this test protocol were that 1) pH remains close to 7.0, which is mandatory to derive valid phosphocreatine (PCr) recovery rates (4), 2) at 85% MVF P motor unit recruitment of large muscles is complete (1, 9) , and 3) the obtained mean decrease in PCr concentration is sufficiently high to calculate PCr recovery rate (k PCr ) (22) .
Processing: Free-induction decays were zero-filled, line-broadened, Fourier-transformed into spectra, and fitted using tdfdfit (35) . Inorganic phosphate (P i ) and PCr concentrations were calculated using ATP as internal reference standard, assuming a concentration of 8.2 mM (4).
The saturation factor in the dynamic spectra was determined by the ratio of the relaxed spectra to the partially saturated spectra acquired prior to the plantarflexion exercise. We calculated k PCr , which is an indirect marker for the maximal rate of oxidative ATP synthesis (31), using a mono-exponential fitting procedure. Intracellular pH-values were calculated from the chemical shift of P i according to the modified Henderson-Hasselbach equation (26) . 8 Sample preparation. We obtained percutaneous biopsies from the middle region of the nondominant soleus and vastus lateralis muscles, using a ProMag Ultra device and 14 gauge needles (Angiotech Pharmaceuticals, Gainesville, FL, USA). Muscle tissue was mounted in an embedding medium (Tissue-Tek ® , Sakura, Zoeterwoude, The Netherlands), snap frozen in isopentane cooled to −160 °C with liquid nitrogen. We stained the serial cryocut crosssections using the myofibrillar adenosinetriphosphatase (mATPase) method according to Guth and Samaha (16) and capillary-to-fiber ratio, showed that 50 fiber measurements per individual for type 1 and 2 fibers and capillary contacts are sufficient to characterize type 1 and 2 fiber areas and capillary-to-fiber ratio of an individual (21, 28) . 9 We used Innocor™ (Innovision, Odense, Denmark) to estimate cardiac output by inert gas rebreathing and oxygen consumption by breath-by-breath ergospirometry during a graded cycling exercise test (GXT), as previously described (12) . Participants started cycling at 50 W and power was increased by 25 W every 2 min until volitional exhaustion. Arterio-venous oxygen difference was calculated by dividing oxygen consumption by cardiac output.
Skeletal muscle biopsy analyses
Cardiac output and oxygen consumption measurements
Ventilatory threshold was determined as the power corresponding with a disproportionate increase in minute ventilation during the GXT.
Endurance capacity
On a separate day, we used a constant-load cycling exercise test (CLT) to assess time to exhaustion at submaximal power as an indicator of endurance capacity. Power of the initial warm-up stage was 40% maximal power of the first GXT. After 1 min, we increased power to 60% peak power (for 2 min) and then to 85% maximal power. Power at 85% maximal power was sustained until volitional exhaustion, i.e. the point in time at which the participants stopped pedaling or were no longer able to maintain pedal rate within the required limits.
Dual-energy X-ray absorptiometry
We performed dual-energy X-ray absorptiometry (DXA) measurements using Lunar iDXA™ (GE Healthcare, Madison, WI, USA).
Blood analyses
Plasma glucose concentrations were determined by an automated hexokinase method (HK Unit-Kit III, Roche, Basel, Switzerland), and serum insulin concentrations were determined by radioimmunoassay (Insulin ct-kit, Cisbio Bioassays, Bagnols-sur-Cèze, France). HbA1c 10 was immunochemically determined with a DCA 2000  device (Bayer, Leverkusen, Germany). Furthermore, CON participants performed a standard 75 g-oral glucose tolerance test (OGTT) in the morning after an overnight (12 h) fast.
Statistical analyses
Data are presented as mean and standard deviation (SD). Group differences between CON and DIA were tested for statistical significance by t-tests for independent samples, and equality of variances was checked using Levene's test. The level of significance was set to P < 0.05. For all statistical analyses, SPSS 16.0 statistical software (SPSS, Chicago, IL, USA) was used.
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RESULTS
Calf muscle mitochondrial capacity
As indicated by the identical post-exercise k PCr for CON and DIA [0.0307 (0.0070) and 0.0309 (0.0058) s −1 , respectively], calculated from the PCr recovery over time (Fig. 1A) , calf muscle mitochondrial capacity was not different (P = 0.930) between the two groups. pH did not affect PCr recovery, as shown by the independency of k PCr from pH (Fig. 1B) . Fig. 1A ) were similar between CON and DIA. Force increased during the initial ~4 s and remained steady during the following ~26 s of isometric plantarflexion (Fig. 1D ).
Skeletal muscle fiber properties
For both, vastus lateralis and soleus muscles, no differences in capillary-to-fiber ratio and MYH-1 fiber percentage were found between CON and DIA ( Fig. 2A, B ). The oxidative fiber phenotype was not different between CON and DIA, as indicated by the similar cytochrome c oxidase activity in MYH-1 and MYH-2 fibers (Fig. 2C) . In general, muscle fiber diameters tended to be smaller for CON relative to DIA (Fig. 2D) . However, only the vastus lateralis muscle MYH-2 mean fiber diameter was significantly (P = 0.006) smaller in CON than in DIA (Fig. 2D ).
Oxygen consumption, cardiac output, and arterio-venous oxygen difference
Oxygen consumption, cardiac output, and calculated arterio-venous oxygen difference were not different between CON and DIA at maximal and submaximal power during a GXT (Fig.   3 ). 
Exercise performance, ventilatory threshold and endurance capacity
Effect of glycemic control on mitochondrial capacity and cardiac output
HbA1c was negatively correlated with k PCr (R 2 = 0.475, P = 0.040, Fig. 4A ) and peak cardiac output (R 2 = 0.742, P = 0.013; Fig. 4B ) in women with type 1 diabetes.
Body composition
Both, total and segmental lean and fat masses, were lower in CON relative to DIA, while % body fat was the same in both groups (Tab. 1). 13 
DISCUSSION
The aim of the present study was to determine whether aerobic function is reduced in women with type 1 diabetes and whether their glycemic status influences mitochondrial capacity. We found that in women with type 1 diabetes, glycemic status affected mitochondrial capacity and cardiac output, but that maximal oxygen uptake, maximal cardiac output, calculated arterio-venous oxygen difference, in vivo skeletal muscle mitochondrial capacity, muscle fiber metabolic phenotype, and capillarization were not different between women with type 1 diabetes and healthy women of similar age and physical activity level. Analogous to maximal aerobic function, we found that ventilatory threshold and endurance capacity were similar between the two groups. Our results indicate that glycemic status affects mitochondrial capacity in women with type 1 diabetes, but that neither maximal nor submaximal aerobic function is reduced in young women with type 1 diabetes relative to healthy controls.
To obtain maximal rates of oxidative ATP synthesis we applied a test protocol that decreased skeletal muscle PCr concentration but left intracellular pH close to 7.0 ( Fig. 1) , the latter being crucial to derive valid PCr recovery rates (4) . Our finding that the calculated maximal rate of oxidative ATP synthesis (mitochondrial capacity) was similar between women with type 1 diabetes compared to healthy controls (Fig. 1 ) conflicts with that of Crowther et al. (8) , who reported slower PCr recovery rates in men with type 1 diabetes relative to agematched controls. Three reasons could possibly help to explain the divergent findings. A first reason might be that Crowther et al. (8) determined mitochondrial capacity from isometric dorsiflexions while we used isometric plantarflexions. Thus, differences in oxidative metabolism between dorsiflexion and plantarflexion muscles might lead to divergent findings. But given the fact that MYH-1 fiber type proportion of tibialis anterior muscle lies between that of soleus and gastrocnemius muscles (33) , it seems unlikely that differences in 14 fiber type distribution represent a reason for discrepancy. A second possible reason might be that in the study by Crowther et al. (8) the participants were not able to sustain the target force of 70−75% MVF P for 30 s [ Figure 2A in (8) ]. Therefore, the drop in pH might have varied between participants, affecting the calculation of PCr recovery rates. We avoided this possible drawback by providing the participants with a real-time visual feedback on F P relative to MVF P . This way all our study participants sustained the target force of 85% MVF P for ~30 s (Fig. 1D) . Finally, the discrepancy between our results and those of Crowther et al. Our findings that cytochrome c oxidase activity, capillary-to-fiber ratio, and MYH-1 fiber proportion of vastus lateralis and soleus muscles were not different between the two groups support our result that in vivo mitochondrial capacity was not impaired in women with type 1 diabetes, and lend further credence to the notion that the oxidative metabolism is not impaired in type 1 diabetes. In line with our results, other authors found no difference in vastus lateralis muscle succinate dehydrogenase activity (13) , skeletal muscle capillary-tofiber ratio and fiber type distribution in vastus lateralis muscle (38) between patients with type 1 diabetes and healthy controls. However, there are also reports showing that MYH-1 fiber proportion in women and men with type 1 diabetes (13) is reduced. Besides muscle fiber metabolism, mitochondrial capacity also depends on muscle capillarization. In fact, the size of the capillary network determines mean red blood cell transit time and surface area for gas exchange and may also influence the exchange of substrates and metabolites and removal of heat (34) . However, capillary density relates more to submaximal (e.g. endurance capacity and ventilatory threshold) than to maximal measures (32) . In this study, neither capillarization nor endurance capacity or ventilatory threshold were reduced in women with 15 type 1 diabetes relative to healthy controls, indicating that submaximal aerobic function was not impaired in women with type 1 diabetes.
It has been unclear up to now, whether maximal oxygen uptake and exercise performance (i.e. maximal power output during a GXT) are reduced in type 1 diabetes. While some authors reported that adolescents with type 1 diabetes display both reduced oxygen uptake (15, 24) and peak power (24) other investigators showed that these measures are unchanged in adults with type 1 diabetes (13, 17, 37) . Here, we showed that neither maximal oxygen uptake (Fig. 3A) nor maximal power during a GXT was different between patients with type 1 diabetes and healthy controls. Furthermore, the similar maximal oxygen uptake between the two groups relied on similar perfusive (cardiac output, Fig. 3B ) and diffusive (calculated arterio-venous oxygen difference, Fig. 3C ) oxygen transport capacities, indicating that submaximal and maximal oxygen uptake, delivery and extraction are not reduced in women with type 1 diabetes.
It is well established that reduced insulin sensitivity is a prominent feature of type 2 diabetes.
However, reduced insulin sensitivity can also be found in individuals with type 1 diabetes (10, 17) . We did not assess insulin sensitivity in this study and thus cannot quantify to which degree the type 1 diabetes participants were insulin resistant. Nevertheless, according to evidence indicating that type 1 diabetes patients are insulin resistant to some degree, and assuming that the type 1 individuals who participated in this study were not different in this regard, our data might be interpreted to support the suggestion of other scientists (18) that insulin resistance is not the consequence of reduced mitochondrial capacity. Our finding that skeletal muscle mitochondrial capacity was not impaired in women with type 1 diabetes despite higher total and segmental fat masses (Tab. 1) supports this speculation, i.e. that 16 reduced mitochondrial capacity is not instrumental to insulin resistance, especially in light of the negative correlation between both abdominal (7) and thigh fat (14) and insulin sensitivity.
HbA1c levels above 7% are indicative of poor glycemic control in type 1 diabetes (2) . In this regard, it has recently been shown that endurance athletes with type 1 diabetes and high (> 7%) HbA1c have lower peak oxygen consumption, peak stroke volume, and peak cardiac output relative to athletes with low (< 7%) HbA1c (5) , and that HbA1c negatively correlates with peak stroke volume. Although we did not find a reduced mitochondrial capacity and aerobic function in women with type 1 diabetes with a mean HbA1c of 7.6% (range 6.9−8.2%) relative to healthy female participants, linear regression revealed that women with type 1 diabetes exhibiting higher HbA1c have a lower k PCr and peak cardiac output ( Fig. 4 ).
On the one hand, the level of hyperglycemia might thus affect the function of the heart. In fact, it has been shown in humans that the increase in glycemic control due to insulin pump therapy positively correlated with the increase in systolic function of the left ventricle (3). On the other hand, hyperglycemia might affect mitochondrial function by increasing the input of reducing equivalents into the mitochondrial electron transport chain, which leads to an increase in the production of reactive oxygen species (ROS) (6, 25) . Furthermore, in vitro data revealed that extended exposure to high glucose conditions leads to increased ROS production and a concomitant change in mitochondrial morphology (39) . Taken together, our data might be interpreted to support the notion that hyperglycemia impairs mitochondrial capacity and cardiac function, but that in patients with type 1 diabetes only at higher HbA1c levels (> 7.6%) the impairment becomes significant relative to untrained healthy women.
We do acknowledge some limitations with the current investigation. For example, we calculated arterio-venous oxygen difference from the estimated oxygen uptake and cardiac output according to the Fick principle, instead of calculating arterio-venous oxygen difference and oxygen extraction from measured arterial and venous oxygen content and arterial oxygen concentration. A further limitation is that we did not directly estimate insulin sensitivity from euglycemic hyperinsulinemic clamps nor hepatic glucose production.
However, the primary aim of this study was to determine the relationship between type 1 diabetes and aerobic function, irrespective of the degree of insulin resistance. We thus feel like our approach of combining non-invasive inert gas rebreathing with gas exchange measurements (to assess maximal oxygen uptake and cardiac output), to subsequently calculate stroke volume and arterio-venous oxygen difference according to the Fick principle, and to relate these systemic measures with in vivo calculated maximal mitochondrial ATP synthesis rate and oxidative markers from muscle biopsies, provides novel information about the relationship between aerobic function and its underlying components in type 1 diabetes.
Perspectives and Significance
The available data concerning the relationship between aerobic function and type 1 diabetes are contradicting. Furthermore, there exist no studies, which concurrently investigated skeletal muscle structure as well as in vivo metabolic function and their relationship to maximal oxygen uptake and cardiac output. In the present study, we used an integrative approach to concurrently investigate several elements determining aerobic function. The novelty of this study is that in young untrained women with type 1 diabetes and a mean HbA1c of 7.6% (range 6.9-8.2%), glycemic status affected mitochondrial capacity and peak cardiac output, but that neither maximal nor submaximal aerobic function were reduced relative to healthy women of similar age and activity level. These findings point towards an important role for glycemic status in influencing aerobic function. Therefore, exercise effects in type 1 diabetes should be investigated as a function of glycemic status. Furthermore, in 18 order to improve aerobic function, patients with type 1 diabetes may be advised to improve their individual glycemic status before or while engaging in a regular exercise training program to maximize aerobic function. 
